Skip to main content
. 2021 Dec 6;19:406. doi: 10.1186/s12951-021-01154-2

Table 1.

Identification of 29 significant risk genes by using integrative genomics analysis

Gene name Z score P value (S-MultiXcan) FDR (S-MultiXcan) FDR (S-PrediXcan on liver) FDR (S-PrediXcan on blood) FDR (MAGMA analysis of GWAS) P value (Differential gene expression analysis) GWAS_Catalog database or PubMed database
CSNK2B 1.40 7.17 × 10–19 8.41 × 10–16 3.22 × 10–11 2.24 × 10–6 1.67 × 10–11 4.96 × 10–4 (Blood), 2 × 10–2 (CD14 + T cell) Novel gene
LY6G5B − 7.92 2.43 × 10–16 1.93 × 10–13 5.52 × 10–11 1.54 × 10–10 1.19 × 10–11 Non-significant Novel gene
DDAH2 − 5.57 1.39 × 10–15 9.99 × 10–13 2.65 × 10–9 1.56 × 10–11 1.69 × 10–9 2.70 × 10–3 (CD14 + T cell) Novel gene
LY6G5C − 7.82 2.40 × 10–15 1.62 × 10–12 8.64 × 10–13 9.05 × 10–12 1.41 × 10–11 2.80 × 10–2 (Blood) Novel gene
IRF5 7.11 2.62 × 10–15 1.72 × 10–12 4.29 × 10–13 1.12 × 10–12 7.18 × 10–11 7.10 × 10–3 (Liver) Reported gene
SOCS1 − 3.26 9.33 × 10–13 4.16 × 10–10 5.25 × 10–10 7.34 × 10–10 1.06 × 10–8 3.50 × 10–2 (CD14 + T cell) Reported gene
SYNGR1 − 1.30 2.83 × 10–9 8.88 × 10–7 7.97 × 10–4 1.30 × 10–7 4.13 × 10–2 1.40 × 10–2 (CD14 + T cell) Reported gene
C6orf48 − 4.46 9.57 × 10–9 2.66 × 10–6 7.83 × 10–4 6.19 × 10–4 4.83 × 10–11 4.16 × 10–6 (Blood) Novel gene
HLA-DMA − 3.99 8.87 × 10–8 1.90 × 10–5 1.27 × 10–3 9.16 × 10–4 1.62 × 10–8 2.10 × 10–3 (Liver) Novel gene
SMC4 − 1.34 1.00 × 10–7 2.10 × 10–5 9.38 × 10–5 2.25 × 10–6 2.07 × 10–4 4.80 × 10–4 (Blood) Novel gene
TCF19 4.55 1.49 × 10–7 2.99 × 10–5 9.46 × 10–5 2.24 × 10–6 1.98 × 10–4 Non-significant Novel gene
ORMDL3 − 2.92 7.07 × 10–7 1.22 × 10–4 2.35 × 10–3 7.38 × 10–5 2.33 × 10–6 3.5 × 10–2 (Liver) Reported gene
KPNA4 − 1.22 1.07 × 10–6 1.82 × 10–4 2.10 × 10–2 3.58 × 10–3 4.67 × 10–4 3.40 × 10–3 (CD14 + T cell) Novel gene
MANBA − 1.45 1.48 × 10–6 2.35 × 10–4 2.46 × 10–6 2.39 × 10–2 8.30 × 10–8 9.67 × 10–5 (Blood) Reported gene
MFSD6 − 0.32 1.61 × 10–6 2.51 × 10–4 2.55 × 10–2 4.57 × 10–2 2.06 × 10–3 3.60 × 10–2 (Liver) Novel gene
MED1 − 2.13 1.76 × 10–6 2.70 × 10–4 1.65 × 10–2 1.53 × 10–2 4.42 × 10–5 Non-significant Novel gene
IDUA 3.95 2.37 × 10–6 3.47 × 10–4 3.94 × 10–2 3.87 × 10–2 8.95 × 10–4 8.10 × 10–3 (Blood) Reported gene
DGKQ 3.24 3.86 × 10–6 5.37 × 10–4 4.90 × 10–4 3.36 × 10–4 2.35 × 10–4 8.34 × 10–7 (Blood) Reported gene
FCRL3 − 4.40 8.14 × 10–6 1.07 × 10–3 2.84 × 10–3 2.84 × 10–3 5.81 × 10–4 Non-significant Reported gene
ZCRB1 3.22 9.34 × 10–6 1.20 × 10–3 4.83 × 10–3 5.02 × 10–3 1.52 × 10–3 5.90 × 10–3 (Liver); 2.8 × 10–3 (CD14 + T cell); Novel gene
AGAP5 − 4.28 1.29 × 10–5 1.59 × 10–3 4.50 × 10–3 3.40 × 10–3 3.65 × 10–2 Non-significant Novel gene
CARM1 − 2.90 2.11 × 10–5 2.49 × 10–3 1.14 × 10–3 8.92 × 10–4 1.86 × 10–4 2.60 × 10–2 (Blood) Novel gene
UBE2D3 − 4.18 2.83 × 10–5 3.23 × 10–3 2.76 × 10–3 5.08 × 10–3 5.81 × 10–4 3.40 × 10–2 (Blood); 1.6 × 10–4 (CD14 + T cell) Novel gene
NAAA 4.08 6.73 × 10–5 6.88 × 10–3 1.25 × 10–2 6.85 × 10–3 7.41 × 10–4 3.20 × 10–2 (Liver) Reported gene
SH2B3 − 1.69 1.20 × 10–4 1.17 × 10–2 2.35 × 10–2 1.87 × 10–2 2.44 × 10–3 1.40 × 10–2 (Blood) Reported gene
CTSH 1.75 2.05 × 10–4 1.84 × 10–2 8.53 × 10–3 3.46 × 10–2 2.19 × 10–5 Non-significant Novel gene
TTC34 3.56 2.82 × 10–4 2.39 × 10–2 5.86 × 10–3 5.02 × 10–3 4.98 × 10–3 9.80 × 10–3 (Blood) Novel gene
METTL1 2.19 3.11 × 10–4 2.59 × 10–2 4.95 × 10–2 3.81 × 10–2 1.68 × 10–2 5.86 × 10–7 (Blood) Novel gene
TSFM 3.45 3.14 × 10–4 2.61 × 10–2 4.87 × 10–2 3.87 × 10–2 1.54 × 10–2 2.80 × 10–4 (Blood); 1.5 × 10–3 (CD14 + T cell) Novel gene